ViaCord (Biotechnology, Health Care) — Funding, Investors & Signals 2026

ViaCord

We're a family cord blood and cord tissue stem cell bank. Rooted in science. Obsessed with quality.

Founded 1993

Cambridge, United States 86 employees Series Unknown Total: $68.00M Biotechnology, Health Care

ViaCord is a family cord blood and cord tissue stem cell bank founded in 1993. The company's slogan "Rooted in science. Obsessed with quality." reflects its commitment to providing the highest-quality stem cell preservation service and care to patients, families, and their physicians. ViaCord's mission to bank children's cord blood with comfort and security has been its focus since establishment. ViaCord has built strong partnerships with renowned institutions such as the Obstetrics Program at Brigham and Women's Hospital in Boston, MA, The Christ Hospital in Cincinnati, OH, and The University of Cincinnati's Hoxworth Blood Center. The company's headquarters are based in Cambridge, Massachusetts, a recognized global hub of biotechnology. The cord blood collections are processed and stored at a dedicated facility outside of Cincinnati. Having received a $20.00M Venture Round investment on 02 January 2004 from Amgen Ventures, ViaCord has demonstrated potential and attracted notable investment interest. With a focus on Biotechnology and Health Care industries, ViaCord's dedication to quality and science makes it a promising player in the field of stem cell banking.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	1		02 Jan 2004
Venture Round	••••••	5	•••• ••••	14 Nov 2000

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

02 Jan 2004

Venture Round

••••••

•••• ••••

14 Nov 2000

FAQ About ViaCord

We're a family cord blood and cord tissue stem cell bank. Rooted in science. Obsessed with quality.

ViaCord was founded in 1993.

ViaCord is headquartered in Cambridge, United States.

ViaCord operates in the following industries: Biotechnology, Health Care.

ViaCord has approximately 86 employees.

ViaCord has completed 2 funding rounds, raising a total of $68.00M. The latest funding stage is Series Unknown.

Top alternatives and competitors to ViaCord include Insception Lifebank Cord Blood Program, Cells4Life Group LLP, Cryovault Biotech India, Cryo-Cell, HealthBaby Biotech (Hong Kong) Co., Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ViaCord and Insception Lifebank Cord Blood Program are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

ViaCord

General Information

Track ViaCord

Discover More

About ViaCord

Funding Rounds & Investors (2)

ViaCord Alternatives & Competitors

FAQ About ViaCord

Don't just browse. Track.